Skip to content

Clinical trials

Observational Fatty Liver trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Phase: Observational Country / region: China Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20121
20141
20154
20172
20182
20201
20211
20222
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10
Completed4
Recruiting4
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Friendship Hospital3
Beijing Jishuitan Hospital2
Fatty Liver and Alcoholic Liver Disease Study Group, China2
Beijing Municipal Administration of Hospitals1
Chongqing Medical University1
Dong Peng1
Fifth Affiliated Hospital, Sun Yat-Sen University1
First Affiliated Hospital of Chongqing Medical University1
Hospital Authority, Hong Kong1
Nanfang Hospital, Southern Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver20
Liver Cirrhosis7
Non-alcoholic Fatty Liver Disease6
Fibrosis3
Metabolic Syndrome3
Obesity3
Diabetes Mellitus2
Hepatitis2
Hepatitis B, Chronic2
Hypertension2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.